MCF Advisors’s Otonomy, Inc. OTIC Stock Holding History

MCF Advisors’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-450	Closed	-$1K	–	754
2021 Q3	$1K	Buy	+450	New	+$763	﹤0.01%	753

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCF Advisors's OTIC Position: Q4 2021 in Review

MCF Advisors sold out of Otonomy, Inc. (OTIC) in Q4 2021, closing a stake of 450 shares — an estimated $1K sold.

MCF Advisors first reported a position in OTIC in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 44 funds tracked by Wall St. Rank hold OTIC as of Q4 2021.

MCF Advisors reported no remaining Otonomy, Inc. position as of Q4 2021 after selling out during the quarter.
MCF Advisors sold 450 Otonomy, Inc. shares in Q4 2021, an estimated $1K.
MCF Advisors first reported a position in Otonomy, Inc. in Q3 2021 and held it in 1 quarter.
MCF Advisors's Otonomy, Inc. position peaked at $1K in Q3 2021.
44 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q4 2021.

Based on MCF Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.